| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 206.898 | 84 |
| GSM780708 | Untreated after 4 days (C2_1) | 180.98 | 83 |
| GSM780709 | Untreated after 4 days (C3_1) | 150.332 | 80 |
| GSM780719 | Untreated after 4 days (C1_2) | 214.634 | 84 |
| GSM780720 | Untreated after 4 days (C2_2) | 190.805 | 83 |
| GSM780721 | Untreated after 4 days (C3_2) | 154.462 | 81 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 210.432 | 84 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 215.524 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 271.865 | 87 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 220.976 | 85 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 231.48 | 85 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 294.047 | 87 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 163.765 | 81 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 198.759 | 83 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 202.137 | 84 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 163.5 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 202.586 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 193.513 | 83 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 203.405 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 167.96 | 82 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 206.306 | 84 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 183.124 | 83 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 175.313 | 82 |